High-dose intensity-modulated radiotherapy for prostate cancer using daily fiducial marker-based position verification: acute and late toxicity in 331 patients

We evaluated the acute and late toxicity after high-dose intensity-modulated radiotherapy (IMRT) with fiducial marker-based position verification for prostate cancer. Between 2001 and 2004, 331 patients with prostate cancer received 76 Gy in 35 fractions using IMRT combined with fiducial marker-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Lips, Irene M, Dehnad, Homan, van Gils, Carla H, Boeken Kruger, Arto E, van der Heide, Uulke A, van Vulpen, Marco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430572/
https://www.ncbi.nlm.nih.gov/pubmed/18495016
http://dx.doi.org/10.1186/1748-717X-3-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430572/
https://www.ncbi.nlm.nih.gov/pubmed/18495016
http://dx.doi.org/10.1186/1748-717X-3-15

Ejemplares similares